Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Highlands Oncology Group - Fayetteville, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Muscle Invasive Bladder Urothelial Carcinoma · Stage IV Lung Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Ovarian Cancer

Recently updated registry entries

NCT07198074 — Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin… (Recruiting)
NCT06337318 — Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden… (Recruiting)
NCT06580314 — Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.